<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sibmed</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский научный медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Сибирский научный медицинский журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-2512</issn><issn pub-type="epub">2410-2520</issn><publisher><publisher-name>ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/SSMJ20240414</article-id><article-id custom-type="elpub" pub-id-type="custom">sibmed-1622</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Артериальная ригидность и генетический полиморфизм некоторых цитокинов у нормотензивных больных анкилозирующим спондилитом</article-title><trans-title-group xml:lang="en"><trans-title>Arterial stiffness and genetic polymorphism of some cytokines in normotensive patients with ankylosing spondylitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4957-5908</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аксенова</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Aksenova</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аксенова Татьяна Александровна, д.м.н.</p><p>672000, г. Чита, ул. Горького, 39а </p></bio><bio xml:lang="en"><p>Tatiana A. Aksenova, doctor of medical sciences</p><p>672000, Chita, Gorkogo st., 39a </p></bio><email xlink:type="simple">tatianaks@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1818-5325</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иващенко</surname><given-names>Н. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivashchenko</surname><given-names>N. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иващенко Наталия Федоровна, к.м.н.</p><p>672000, г. Чита, ул. Горького, 39а </p></bio><bio xml:lang="en"><p>Nataliya F. Ivashchenko, candidate of medical sciences</p><p>672000, Chita, Gorkogo st., 39a </p></bio><email xlink:type="simple">betsij@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4340-4315</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скобова</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Skobova</surname><given-names>J. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Скобова Юлия Владимировна</p><p>672000, г. Чита, ул. Горького, 39а </p></bio><bio xml:lang="en"><p>Julia V. Skobova</p><p>672000, Chita, Gorkogo st., 39a </p></bio><email xlink:type="simple">yskobova@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2032-7612</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щербак</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shcherbak</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щербак Владимир Александрович, д.м.н., проф.</p><p>672000, г. Чита, ул. Горького, 39а </p></bio><bio xml:lang="en"><p>Vladimir A. Shcherbak, doctor of medical sciences, professor</p><p>672000, Chita, Gorkogo st., 39a </p></bio><email xlink:type="simple">shcherbak2001@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7065-5737</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Царенок</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsarenok</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Царенок Светлана Юрьевна, д.м.н.</p><p>672000, г. Чита, ул. Горького, 39а </p></bio><bio xml:lang="en"><p>Svetlana Yu. Tsarenok, doctor of medical sciences</p><p>672000, Chita, Gorkogo st., 39a </p></bio><email xlink:type="simple">sveta-tsarenok@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3811-2943</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горбунов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorbunov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Горбунов Владимир Владимирович, д.м.н., проф.</p><p>672000, г. Чита, ул. Горького, 39а </p></bio><bio xml:lang="en"><p>Vladimir V. Gorbunov, doctor of medical sciences, professor</p><p>672000, Chita, Gorkogo st., 39a </p></bio><email xlink:type="simple">gorbunovvv2008@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Читинская государственная медицинская академия Минздрава России<country>Россия</country></aff><aff xml:lang="en">Chita State Medical Academy of Minzdrav of Russia<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>30</day><month>08</month><year>2024</year></pub-date><volume>44</volume><issue>4</issue><fpage>126</fpage><lpage>133</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Аксенова Т.А., Иващенко Н.Ф., Скобова Ю.В., Щербак В.А., Царенок С.Ю., Горбунов В.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Аксенова Т.А., Иващенко Н.Ф., Скобова Ю.В., Щербак В.А., Царенок С.Ю., Горбунов В.В.</copyright-holder><copyright-holder xml:lang="en">Aksenova T.A., Ivashchenko N.F., Skobova J.V., Shcherbak V.A., Tsarenok S.Y., Gorbunov V.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://sibmed.elpub.ru/jour/article/view/1622">https://sibmed.elpub.ru/jour/article/view/1622</self-uri><abstract><p>Цель исследования – выявить частоту встречаемости артериальной ригидности (АР) у нормотензивных больных анкилозирующим спондилитом (АС) в Забайкальском крае, изучить полиморфизм генов некоторых цитокинов и прогностические факторы повышения АР при данном заболевании. Материал и методы. Обследовано 100 пациентов с АС, HLA-В27-позитивных, уроженцев Забайкальского края, и 100 здоровых лиц контрольной группы (КГ), HLA-B27-негативных; все включенные в исследование были европеоидной расы. Артериальные гипертензии являлись критерием исключения. Определение однонуклеотидных полиморфизмов генов IL1B (‒31T/C, rs1143627), IL10 (‒592C/A, rs1800872), IL10 (‒819C/T, rs1800871), TNF (‒308G/A, rs1800629) проведено всем пациентам с АС и лицам КГ. 74 больным АС и 40 лицам КГ выполнена аппланационная тонометрия с помощью прибора SphygmoCor (AtCor Medical, Австралия). Результаты. Скорость распространения пульсовой волны на каротидно-феморальном сегменте у больных АС составила 6,5 [4,1; 11,7] м/с, у лиц КГ – 5,2 [3,9; 7,0] м/с (р = 0, 0001). У 18 пациентов с АС (24,32 %) она была больше возрастной нормы, эти пациенты составили группу с повышенной АР. У больных АС носительство гомозиготного генотипа АА гена IL10 (полиморфизм rs1800872, позиция ‒592C/A) встречалось в 2,18 раза чаще, гомозиготного генотипа GG гена TNF – в 1,23 раза чаще, гетерозиготного генотипа СТ гена IL10 (полиморфизм rs1800871, позиция ‒819C/T) ‒ в 1,5 раза чаще, чем в КГ. Прогностическими факторами повышения АР у больных АС явились носительство полиморфизма rs1143627 гена, кодирующего ИЛ-1β, возраст и рентгенологическая стадия изменений в крестцово-подвздошных суставах. Заключение. Повышенная АР выявлена у 24,3 % нормотензивных больных АС. Генотип СТ гена IL10 (полиморфизм rs1800871, позиция ‒819C/T), АА гена IL10 (полиморфизм rs1800872, позиция ‒592C/A), аллель G и генотип GG гена TNF (полиморфизм rs1800629, позиция ‒308G/A) ассоциированы с развитием АС у лиц европеоидной расы. Многофакторным регрессионным анализом выявлены клинико-генетические факторы, прогнозирующие повышение АР у больных АС, уроженцев Забайкальского края.</p></abstract><trans-abstract xml:lang="en"><p>Aim of the study was to identify the incidence of arterial stiffness in normotensive patients with ankylosing spondylitis (AS) in the Trans-Baikal region, to study polymorphism of genes for some cytokines and prognostic factors for increased arterial stiffness in this disease. Material and methods. We examined 100 patients with AS, natives of the Transbaikal region, HLA-В27 positive and 100 healthy controls, HLA-B27 negative; all included in the study were Caucasian. Arterial hypertension was an exclusion criterion. Determination of single nucleotide polymorphisms of the genes IL1B (‒31T/C, rs1143627), IL10 (‒592C/A, rs1800872), IL10 (‒819C/T, rs1800871), TNF (‒308G/A, rs1800629) was carried out in all patients with AS and healthy individuals. 74 patients with AS and 40 patients in the control group underwent applanation tonometry using SphygmoCor (AtCor Medical, Australia). Results. Pulse wave velocity on the carotid-femoral segment in patients with AS was 6.5 [4.1; 11.7] m/s, in the control group – 5.2 [3.9; 7.0] m/s (p = 0.0001). In 18 patients with AS (24.32 %) it was more than the age norm, these patients made up the group with elevated arterial stiffness. In patients with AS, carriage of the homozygous AA genotype of the IL10 gene (rs1800872, ‒592C/A) was 2.18 times more common, the homozygous GG genotype of the TNF gene (rs1800629, ‒308G/A) was 1.23 times more common, and the heterozygous ST genotype of the IL10 gene (rs1800871, ‒819C/T) was 1.5 times more common than in the control group. Prognostic factors for increased arterial stiffness in patients with AS were carriage of the IL10 rs1800871 polymorphism, age, and the radiological stage of changes in the sacroiliac joints. Conclusions. Increased arterial stiffness was detected in 24.3 % of normotensive patients with AS. The CT genotype of the IL10 gene (rs1800871, ‒819C/T), AA genotype of the of the IL10 gene (rs1800872, ‒592C/A), the G allele and the GG genotype of the TNF gene (rs1800629, позиция ‒308G/A) are associated with the development of AS in Caucasians. Multivariate regression analysis identified clinical and genetic factors that predict an increase in arterial stiffness in patients with AS, natives of the Trans-Baikal Territory.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>анкилозирующий спондилит</kwd><kwd>артериальная ригидность</kwd><kwd>скорость распространения пульсовой волны</kwd><kwd>однонуклеотидный полиморфизм генов цитокинов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ankylosing spondylitis</kwd><kwd>arterial stiffness</kwd><kwd>pulse wave velocity</kwd><kwd>single nucleotide polymorphisms of cytokine’s genes</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dashti N., Mahmoudi М., Aslani S., Jamshidi A. HLA-B27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene. 2018;670:15– 21. doi: 10.1016/j.gene.2018.05.092</mixed-citation><mixed-citation xml:lang="en">Dashti N., Mahmoudi М., Aslani S., Jamshidi A. HLA-B27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene. 2018;670:15– 21. doi: 10.1016/j.gene.2018.05.092</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lei L., Baolan S., Wenkai Z., Wenhua X., Yan Z., Feng L., Daqi X., Tianbo J., Yong Z., Xuejun Y. Association of IL-1A and IL-1B polymorphisms with ankylosing spondylitis among the Chinese Han population: a case-control study. Oncotarget. 2017;8(17):28278– 28284. doi: 10.18632/oncotarget.16004</mixed-citation><mixed-citation xml:lang="en">Lei L., Baolan S., Wenkai Z., Wenhua X., Yan Z., Feng L., Daqi X., Tianbo J., Yong Z., Xuejun Y. Association of IL-1A and IL-1B polymorphisms with ankylosing spondylitis among the Chinese Han population: a case-control study. Oncotarget. 2017;8(17):28278– 28284. doi: 10.18632/oncotarget.16004</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Yi X., Yan L., Shi G., Jie-Gen Y., Meng-Sha T., Peng-Hui X., Fen-Dui Q., Guo-Pin W. Association between cytokine gene polymorphisms and ankylosing spondylitis susceptibility: a systematic review and meta-analysis. Postgrad. Med. J. 2018;94(1115):508–516. doi: 10.1136/postgradmedj-2018-135665</mixed-citation><mixed-citation xml:lang="en">Yi X., Yan L., Shi G., Jie-Gen Y., Meng-Sha T., Peng-Hui X., Fen-Dui Q., Guo-Pin W. Association between cytokine gene polymorphisms and ankylosing spondylitis susceptibility: a systematic review and meta-analysis. Postgrad. Med. J. 2018;94(1115):508–516. doi: 10.1136/postgradmedj-2018-135665</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Крылов М.Ю., Гусева И.А., Сахарова К.В., Самаркина Е.Ю., Эрдес Ш.Ф., Коновалова Н.В., Варламов Д.А. Участие полиморфизмов генов TNF, CRP и SAA1 в формировании предрасположенности к развитию анкилозирующего спондилита и его клинических проявлений. Научно-практ. ревматол. 2022;60(1):64–71. doi: 10.47360/1995-4484-2022-64-71</mixed-citation><mixed-citation xml:lang="en">Krylov M.Yu., Guseva I.A., Sakharova K.V., Samarkina E.Yu., Erdes Sh.F., Konovalova N.V., Varlamov D.A. Involvement of polymorphisms of TNF, CRP and SAA1 genes in the predisposition to the development of ankylosing spondylitis and its clinical manifestations. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2022;60(1):64–71 [In Russian]. doi: 10.47360/1995-4484-2022-64-71</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Himanshu R., Joner М., Wilson Н., McGovern L., Richards G., Colleran R., Byrne R. Interleukin-10 -1082 G/A polymorphism and its association with early or severe presentation of coronary artery disease: A systematic review and meta-analysis. Cytokine. 2023;162:156103. doi: 10.1016/j.cyto.2022.156103</mixed-citation><mixed-citation xml:lang="en">Himanshu R., Joner М., Wilson Н., McGovern L., Richards G., Colleran R., Byrne R. Interleukin-10 -1082 G/A polymorphism and its association with early or severe presentation of coronary artery disease: A systematic review and meta-analysis. Cytokine. 2023;162:156103. doi: 10.1016/j.cyto.2022.156103</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hettwer J., Hinterdobler J., Miritsch B., Deutsch M.A., Li X., Mauersberger C., Moggio A., Braster Q., Gram H., Robertson A.A., … Sager H.B. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis. Cardiovasc. Res. 2022;118(13):2778–2791. doi: 10.1093/cvr/cvab337</mixed-citation><mixed-citation xml:lang="en">Hettwer J., Hinterdobler J., Miritsch B., Deutsch M.A., Li X., Mauersberger C., Moggio A., Braster Q., Gram H., Robertson A.A., … Sager H.B. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis. Cardiovasc. Res. 2022;118(13):2778–2791. doi: 10.1093/cvr/cvab337</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bennet A.M., van Maarle M.C., Hallqvist J., Morgenstern R., Frostegård J., Wiman B., Prince J.A., de Faire U. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Аtherosclerosis. 2006;187(2):408–414. doi: 10.1016/j.atherosclerosis.2005.09.022</mixed-citation><mixed-citation xml:lang="en">Bennet A.M., van Maarle M.C., Hallqvist J., Morgenstern R., Frostegård J., Wiman B., Prince J.A., de Faire U. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Аtherosclerosis. 2006;187(2):408–414. doi: 10.1016/j.atherosclerosis.2005.09.022</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">van Bortel L.M., Laurent S., Boutouyrie P., Chowienczyk P., Cruickshank J.K., Backer T.D., Filipovsky J., Huybrechts S., Mattace-Raso F.U.S., Protogerou A.D., … European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J. Hypertens. 2012;30(3):445–453. doi: 10.1097/HJH.0b013e32834fa8b0</mixed-citation><mixed-citation xml:lang="en">van Bortel L.M., Laurent S., Boutouyrie P., Chowienczyk P., Cruickshank J.K., Backer T.D., Filipovsky J., Huybrechts S., Mattace-Raso F.U.S., Protogerou A.D., … European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J. Hypertens. 2012;30(3):445–453. doi: 10.1097/HJH.0b013e32834fa8b0</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гуреева Н.А. Горяйнов И.И., Степченко М.А. Изменения параметров жесткости артериального русла у больных болезнью Бехтерева на фоне лечения инфликсимабом. Вестн. нов. мед. технол. 2012;19(4):94–96.</mixed-citation><mixed-citation xml:lang="en">Gureeva N.A., Goryanov I.I., Stepchenko M.A. The changes of vessel wall rigidity in patient with ankylosing spondilitis treated with infliximab. Vestnik novykh meditsinskikh tekhnologiy = Journal of New Medical Technologies. 2012;19(4):94–96. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Гайдукова И.З., Маслянский А.Л., Полянская О.Л., Колесова Е.П., Ребров А.П., Конради А.О. Жесткость сосудистой стенки у пациентов с анкилозирующим спондилитом (результаты многоцентрового исследования). Клиницист. 2015;9(3):28–33. doi: 10.17650/1818-8338-2015-9-3-28-33</mixed-citation><mixed-citation xml:lang="en">Gaydukova I.Z., Maslyansky A.L., Polyanskaya O.L., Kolesova E.P., Rebrov A.P., Konradi A.O. Vascular wall stiffeness in patients with ankylosing spondilitis: results of a mylticenter study. Klinitsist = The Clinician 2015;9(3):28–33. [In Russian]. doi: 10.17650/1818-8338-2015-9-3-28-33</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Karkucak M., Çapkin E., A Kiriş., Şahin M., Küçükali Türkyilmaz A., Karaca A., Gökmen F., Ayar A. Arterial stiffness and anti-tumor necrosis factor-alpha therapy in ankylosing spondylitis: results with long-term two year-follow-up. Arch. Rheumatol. 2014;29(4):250–256. doi: 10.5606/ArchRheumatol.2014.4261</mixed-citation><mixed-citation xml:lang="en">Karkucak M., Çapkin E., A Kiriş., Şahin M., Küçükali Türkyilmaz A., Karaca A., Gökmen F., Ayar A. Arterial stiffness and anti-tumor necrosis factor-alpha therapy in ankylosing spondylitis: results with long-term two year-follow-up. Arch. Rheumatol. 2014;29(4):250–256. doi: 10.5606/ArchRheumatol.2014.4261</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tam L.S., Shang Q., Kun E.W., Lee K.L., Yip M.L, Li M., Li T.K., Zhu T.Y., Pui M.O., Li E.K., Yu C.M. The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis – a randomized, placebo-controlled pilot trial. Rheumatology (Oxford). 2014;53(6):1065–1074. doi: 10.1093/rheumatology/ket469</mixed-citation><mixed-citation xml:lang="en">Tam L.S., Shang Q., Kun E.W., Lee K.L., Yip M.L, Li M., Li T.K., Zhu T.Y., Pui M.O., Li E.K., Yu C.M. The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis – a randomized, placebo-controlled pilot trial. Rheumatology (Oxford). 2014;53(6):1065–1074. doi: 10.1093/rheumatology/ket469</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Szabo S.M., Levy A.R., Rao S.R., Kirbach S.E., Lacaille D., Cifaldi М., Maksymowych W.P. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum. 2011;63(11):3294– 3304. doi: 10.1002/art.30581</mixed-citation><mixed-citation xml:lang="en">Szabo S.M., Levy A.R., Rao S.R., Kirbach S.E., Lacaille D., Cifaldi М., Maksymowych W.P. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum. 2011;63(11):3294– 3304. doi: 10.1002/art.30581</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Berg I.J., Heijde D., Dagfinrud H., Seljeflot I., Olsen I.C., Kvien T.K., Semb A.G., Provan S.A. Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study. J. Rheumatol. 2015;42(4):645–653. doi: 10.3899/jrheum.141018</mixed-citation><mixed-citation xml:lang="en">Berg I.J., Heijde D., Dagfinrud H., Seljeflot I., Olsen I.C., Kvien T.K., Semb A.G., Provan S.A. Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study. J. Rheumatol. 2015;42(4):645–653. doi: 10.3899/jrheum.141018</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kong P., Cui Z.Y., Huang X.F., Zhang D.D., Guo R.J., Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal. Transduct Target. Ther. 2022;7(1):131. doi: 10.1038/s41392-022-00955-7</mixed-citation><mixed-citation xml:lang="en">Kong P., Cui Z.Y., Huang X.F., Zhang D.D., Guo R.J., Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal. Transduct Target. Ther. 2022;7(1):131. doi: 10.1038/s41392-022-00955-7</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu H., Lei X., Liu Q., Wang Y. Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects. Cytokine. 2013;61(1):146–153. doi: 10.1016/j.cyto.2012.09.009</mixed-citation><mixed-citation xml:lang="en">Zhu H., Lei X., Liu Q., Wang Y. Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects. Cytokine. 2013;61(1):146–153. doi: 10.1016/j.cyto.2012.09.009</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lu S., Zhong J., Huang K., Zhou H. Association of IL-10-1082A/G polymorphism with cardiovascular disease risk: Evidence from a case-control study to an updated meta-analysis. Mol. Genet. Genomic Med. 2019;7(11):e888. doi: 10.1002/mgg3.888</mixed-citation><mixed-citation xml:lang="en">Lu S., Zhong J., Huang K., Zhou H. Association of IL-10-1082A/G polymorphism with cardiovascular disease risk: Evidence from a case-control study to an updated meta-analysis. Mol. Genet. Genomic Med. 2019;7(11):e888. doi: 10.1002/mgg3.888</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Иващенко Н.Ф., Аксенова Т.А., Горбунов В.В., Скобова Ю.В., Царенок С.Ю. Генетические полиморфизмы интерлейкина-10 и фактора некроза опухоли-альфа у больных анкилозирующим спондилитом. Забайк. мед. вестн. 2021;(4):69–76. doi 10.52485/19986173_2021_4_69</mixed-citation><mixed-citation xml:lang="en">Ivashchenko N.F., Aksenova T.A., Gorbunov V.V., Skobova Yu.V., Tsarenok S.Yu. The influence of genetic polymorphism of interleukin-10 and tumor necrosis factor-alpha on the development of ankylosing spondylitis. Zabaykal’skiy meditsinskiy vestnik = The Transbaikalian Medical Bulletin. 2021;4:69–76. [In Russian]. doi 10.52485 /19 986173_2021_4_69</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nicknam M.H., Mahmoudi M., Amirzargar A.A., Jamshidi A.R., Rezaei N., Nikbin B. HLA-B27 subtypes and tumor necrosis factor α promoter region polymorphism in Iranian patients with ankylosing spondylitis. Eur. Cytokine Netw. 2009;20(1):17–20. doi: 10.1684/ecn.2009.0143</mixed-citation><mixed-citation xml:lang="en">Nicknam M.H., Mahmoudi M., Amirzargar A.A., Jamshidi A.R., Rezaei N., Nikbin B. HLA-B27 subtypes and tumor necrosis factor α promoter region polymorphism in Iranian patients with ankylosing spondylitis. Eur. Cytokine Netw. 2009;20(1):17–20. doi: 10.1684/ecn.2009.0143</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Levescot J.A., Chang M.H., Schnell J., Nelson-Maney N., Yan J., Martínez-Bonet M., Grieshaber-Bouyer R., Lee P.Y., Wei K., Blaustein R.B., … Nigrovic P.A. IL-1β-driven osteoclastogenic Tregs accelerate bone erosion in arthritis. Clin. Invest. 2021;131(18):e141008. doi: 10.1172/JCI141008</mixed-citation><mixed-citation xml:lang="en">Levescot J.A., Chang M.H., Schnell J., Nelson-Maney N., Yan J., Martínez-Bonet M., Grieshaber-Bouyer R., Lee P.Y., Wei K., Blaustein R.B., … Nigrovic P.A. IL-1β-driven osteoclastogenic Tregs accelerate bone erosion in arthritis. Clin. Invest. 2021;131(18):e141008. doi: 10.1172/JCI141008</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Huynh N.C., Everts V., Pavasant Р., Ampornaramveth R.S. Interleukin-1β induces human cementoblasts to support osteoclastogenesis. J. Oral. Sci. 2017;9(12):e5. doi: 10.1038/ijos.2017.45</mixed-citation><mixed-citation xml:lang="en">Huynh N.C., Everts V., Pavasant Р., Ampornaramveth R.S. Interleukin-1β induces human cementoblasts to support osteoclastogenesis. J. Oral. Sci. 2017;9(12):e5. doi: 10.1038/ijos.2017.45</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
